119 related articles for article (PubMed ID: 29953893)
1. Cholesterol-grafted chitosan micelles as a nanocarrier system for drug-siRNA co-delivery to the lung cancer cells.
Muddineti OS; Shah A; Rompicharla SVK; Ghosh B; Biswas S
Int J Biol Macromol; 2018 Oct; 118(Pt A):857-863. PubMed ID: 29953893
[TBL] [Abstract][Full Text] [Related]
2. Curcumin-loaded chitosan-cholesterol micelles: evaluation in monolayers and 3D cancer spheroid model.
Muddineti OS; Kumari P; Ray E; Ghosh B; Biswas S
Nanomedicine (Lond); 2017 Jun; 12(12):1435-1453. PubMed ID: 28573926
[TBL] [Abstract][Full Text] [Related]
3. SiRNA/DOX lodeded chitosan based nanoparticles: Development, Characterization and in vitro evaluation on A549 lung cancer cell line.
Seifi-Najmi M; Hajivalili M; Safaralizadeh R; Sadreddini S; Esmaeili S; Razavi R; Ahmadi M; Mikaeili H; Baradaran B; Shams-Asenjan K; Yousefi M
Cell Mol Biol (Noisy-le-grand); 2016 Sep; 62(11):87-94. PubMed ID: 27755958
[TBL] [Abstract][Full Text] [Related]
4. Co-delivery of insulin-like growth factor 1 receptor specific siRNA and doxorubicin using chitosan-based nanoparticles enhanced anticancer efficacy in A549 lung cancer cell line.
Shali H; Shabani M; Pourgholi F; Hajivalili M; Aghebati-Maleki L; Jadidi-Niaragh F; Baradaran B; Movassaghpour Akbari AA; Younesi V; Yousefi M
Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):293-302. PubMed ID: 28362176
[TBL] [Abstract][Full Text] [Related]
5. Dual drug-loaded biofunctionalized amphiphilic chitosan nanoparticles: Enhanced synergy between cisplatin and demethoxycurcumin against multidrug-resistant stem-like lung cancer cells.
Huang WT; Larsson M; Lee YC; Liu DM; Chiou GY
Eur J Pharm Biopharm; 2016 Dec; 109():165-173. PubMed ID: 27793756
[TBL] [Abstract][Full Text] [Related]
6. GABA
Ni S; Liu Y; Tang Y; Chen J; Li S; Pu J; Han L
Carbohydr Polym; 2018 Jan; 179():135-144. PubMed ID: 29111036
[TBL] [Abstract][Full Text] [Related]
7. Inhalable bioresponsive chitosan microspheres of doxorubicin and soluble curcumin augmented drug delivery in lung cancer cells.
Jyoti K; Pandey RS; Kush P; Kaushik D; Jain UK; Madan J
Int J Biol Macromol; 2017 May; 98():50-58. PubMed ID: 28130133
[TBL] [Abstract][Full Text] [Related]
8. In vitro biocompatibility and release of curcumin from curcumin microcomplex-loaded chitosan scaffold.
Amirthalingam M; Kasinathan N; Mutalik S; Udupa N
J Microencapsul; 2015; 32(4):364-71. PubMed ID: 25893983
[TBL] [Abstract][Full Text] [Related]
9. Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes.
Gu J; Al-Bayati K; Ho EA
Drug Deliv Transl Res; 2017 Aug; 7(4):497-506. PubMed ID: 28315051
[TBL] [Abstract][Full Text] [Related]
10. Small interfering RNA-loaded chitosan hydrochloride/carboxymethyl chitosan nanoparticles for ultrasound-triggered release to hamper colorectal cancer growth in vitro.
Yan L; Gao S; Shui S; Liu S; Qu H; Liu C; Zheng L
Int J Biol Macromol; 2020 Nov; 162():1303-1310. PubMed ID: 32603733
[TBL] [Abstract][Full Text] [Related]
11. Co-delivery of hypoxia inducible factor-1α small interfering RNA and 5-fluorouracil to overcome drug resistance in gastric cancer SGC-7901 cells.
Chen Y; Sun L; Guo D; Wu Z; Chen W
J Gene Med; 2017 Dec; 19(12):. PubMed ID: 29106062
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and anticervical cancer activity of novel pH responsive micelles for oral curcumin delivery.
Sajomsang W; Gonil P; Saesoo S; Ruktanonchai UR; Srinuanchai W; Puttipipatkhachorn S
Int J Pharm; 2014 Dec; 477(1-2):261-72. PubMed ID: 25455774
[TBL] [Abstract][Full Text] [Related]
13. Effective co-delivery of doxorubicin and curcumin using a glycyrrhetinic acid-modified chitosan-cystamine-poly(ε-caprolactone) copolymer micelle for combination cancer chemotherapy.
Yan T; Li D; Li J; Cheng F; Cheng J; Huang Y; He J
Colloids Surf B Biointerfaces; 2016 Sep; 145():526-538. PubMed ID: 27281238
[TBL] [Abstract][Full Text] [Related]
14. Curcumin-loaded N,O-carboxymethyl chitosan nanoparticles for cancer drug delivery.
Anitha A; Maya S; Deepa N; Chennazhi KP; Nair SV; Jayakumar R
J Biomater Sci Polym Ed; 2012; 23(11):1381-400. PubMed ID: 21722423
[TBL] [Abstract][Full Text] [Related]
15. Ultrasound-Enhanced siRNA Delivery Using Magnetic Nanoparticle-Loaded Chitosan-Deoxycholic Acid Nanodroplets.
Lee JY; Crake C; Teo B; Carugo D; de Saint Victor M; Seth A; Stride E
Adv Healthc Mater; 2017 Apr; 6(8):. PubMed ID: 28195673
[TBL] [Abstract][Full Text] [Related]
16. The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing.
Liu X; Howard KA; Dong M; Andersen MØ; Rahbek UL; Johnsen MG; Hansen OC; Besenbacher F; Kjems J
Biomaterials; 2007 Feb; 28(6):1280-8. PubMed ID: 17126901
[TBL] [Abstract][Full Text] [Related]
17. Transcutaneous iontophoretic delivery of STAT3 siRNA using layer-by-layer chitosan coated gold nanoparticles to treat melanoma.
Labala S; Jose A; Venuganti VV
Colloids Surf B Biointerfaces; 2016 Oct; 146():188-97. PubMed ID: 27318964
[TBL] [Abstract][Full Text] [Related]
18. A self-assembled polyjuglanin nanoparticle loaded with doxorubicin and anti-Kras siRNA for attenuating multidrug resistance in human lung cancer.
Wen ZM; Jie J; Zhang Y; Liu H; Peng LP
Biochem Biophys Res Commun; 2017 Dec; 493(4):1430-1437. PubMed ID: 28958938
[TBL] [Abstract][Full Text] [Related]
19. Induction of apoptosis by chitosan/HPV16 E7 siRNA complexes in cervical cancer cells.
Yang J; Li S; Guo F; Zhang W; Wang Y; Pan Y
Mol Med Rep; 2013 Mar; 7(3):998-1002. PubMed ID: 23258711
[TBL] [Abstract][Full Text] [Related]
20. EGF-modified mPEG-PLGA-PLL nanoparticle for delivering doxorubicin combined with Bcl-2 siRNA as a potential treatment strategy for lung cancer.
Zhang X; Wang Q; Qin L; Fu H; Fang Y; Han B; Duan Y
Drug Deliv; 2016 Oct; 23(8):2936-2945. PubMed ID: 26739487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
